{
  "id": 13608621,
  "title": "Twist Bioscience CEO Emily Leproust sells $919,373 in stock",
  "url": "https://urgent.news/2026/10/11/twist-bioscience-ceo-emily-leproust-sells-919-373-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-11T01:46:09.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/twist-bioscience-ceo-emily-leproust-sells-919373-in-stock-93CH-4942406"
  },
  "original_language": "en",
  "account": null,
  "summary": "Twist Bioscience CEO Emily Leproust sold 4,548 shares of the company's common stock on October 5, 2026, for a total of $919,373, according to an SEC Form 4 filing. The sale was made under a Rule 10b5-1 trading plan adopted in June 2026. Since the transaction, the stock price has declined, currently trading at $159.78, down 15% from the previous week, despite a remarkable 412% return over the last year. Following the sale, Leproust directly holds 562,760 shares of Twist Bioscience common stock.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "InnSuites Hospitality Trust CEO Wirth sells $2.17b in IHT stock",
        "url": "https://urgent.news/2026/10/10/innsuites-hospitality-trust-ceo-wirth-sells-2-17b-in-iht-stock",
        "published": "2026-10-10T22:46:08.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}